ABSI
Absci Corporation
NASDAQ · Healthcare · Biotechnology · US
$8.84
+0.45%Margins
Gross margin
-255.9%
EBITDA margin
-7042.0%
EBIT margin
-8411.3%
Net margin
-7756.4%
FCF margin
-6981.0%
-49.2%
Return on equity
-45.0%
Return on assets
-52.6%
Return on invested capital
0.01x
Asset turnover
-$108.1M
Cash from operations
$1.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026